Sept 22 (Reuters) - BLUEBELL CAPITAL:

* BLUEBELL CAPITAL SENDS LETTER TO CHAIRMAN OF GSK

* BLUEBELL CAPITAL SAYS BELIEVES GSK SHOULD ADDRESS IN THE SHORT TERM, THE LEADERSHIP FOR “NEW GSK”

* BLUEBELL CAPITAL: ASK GSK BOARD TO ACCELERATE FURTHER APPOINTMENTS TO GSK BOARD WITH OBJECTIVE TO INCREASE BIOPHARMACEUTICALS, SCIENTIFIC EXPERIENCE

* BLUEBELL CAPITAL: ASKS GSK TO LAUNCH IMMEDIATELY AFTERWARDS THOROUGH, ROBUST PROCESS TO IDENTIFY BEST(INTERNAL OR EXTERNAL) CANDIDATE TO LEAD NEW GSK

* BLUEBELL CAPITAL: ASKS GSK TO TAKE A PROACTIVE APPROACH TO CONSIDER AVAILABLE ALTERNATIVE TRANSACTIONS TO DEMERGER OF CONSUMER HEALTHCARE

* BLUEBELL CAPITAL SAYS VIEWS GSK VACCINE FRANCHISE AS GENERALLY UNDERVALUED BY MARKET - LETTER

* BLUEBELL WRITES TO GSK IN RELATION TO INVESTMENT AND/OR ECONOMIC INTEREST IN GSK COMMON EQUITY SHARES BY BLUEBELL ACTIVE EQUITY MASTER FUND ICAV

* BLUEBELL CAPITAL SAYS BELIEVES GSK'S EMMA WALMSLEY WOULD HAVE BEEN A VERY CREDIBLE CANDIDATE FOR THE POSITION OF CEO AT CONSUMER HEALTHCARE Further company coverage: